Cor Vasa 2014, 56(4):477-479

Inhibitory ACE, nebo sartany v léčbě hypertenze: zbytečná diskuse?

Doc. MUDr. Jan Václavík, Ph.D.a, MUDr. Jiří Slíva, Ph.D.b
a I. interní klinika - kardiologická, Lékařská fakulta Univerzity Palackého a Fakultní nemocnice Olomouc, Olomouc
b Ústavy farmakologie, 2. a 3. lékařská fakulta Univerzity Karlovy, Praha

Published: August 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Václavík J, Slíva J. Inhibitory ACE, nebo sartany v léčbě hypertenze: zbytečná diskuse? Cor Vasa. 2014;56(4):477-479.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. G. Mancia, R. Fagard, K. Narkiewicz, et al., 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), Journal of Hypertension 31 (2013) 1281-1357. Go to original source... Go to PubMed...
    2. M.R. Law, N.J. Wald, J.K. Morris, R.E. Jordan, Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials, British Medical Journal 326 (2003) 1427. Go to original source... Go to PubMed...
    3. B.S. Heran, M.M. Wong, I.K. Heran, J.M. Wright, Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension, Cochrane Database of Systematic Reviews (4) (2008) CD003822. Go to original source...
    4. M. Burnier, Y. Vuignier, G. Wuerzner, State-of-the-art treatment of hypertension: established and new drugs, European Heart Journal 35 (2014) 557-562. Go to original source... Go to PubMed...
    5. T.W. Doulton, F.J. He, G.A. MacGregor, Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension, Hypertension 45 (2005) 880-886. Go to original source... Go to PubMed...
    6. R. Kunz, C. Friedrich, M. Wolbers, et al., Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease, Annals of Internal Medicine 148 (2008) 30-48. Go to original source... Go to PubMed...
    7. ONTARGET Investigators, S. Yusuf, K.K. Teo, J. Pogue, et al., Telmisartan, ramipril, or both in patients at high risk for vascular events, New England Journal of Medicine 358 (2008) 1547-1559. Go to original source... Go to PubMed...
    8. L.C. van Vark, M. Bertrand, K.M. Akkerhuis, et al., Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients, European Heart Journal 33 (2012) 2088-2097. Go to original source... Go to PubMed...
    9. S. Lewington, R. Clarke, N. Qizilbash, et al., Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet 360 (2002) 1903-1913. Go to original source...
    10. J. Cheng, W. Zhang, X. Zhang, et al., Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis, JAMA Internal Medicine 174 (2014) 773-785. Go to original source... Go to PubMed...
    11. G. Savarese, P. Costanzo, J.G. Cleland, et al., A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure. Journal of the American College of Cardiology 61 (2013) 131-142. Go to original source... Go to PubMed...
    12. E. Lonn, S. Yusuf, V. Dzavik, et al. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE), Circulation 103 (2001) 919-925. Go to original source... Go to PubMed...
    13. G. Corrao, A. Zambon, A. Parodi, et al., Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy, Journal of Hypertension 26 (2008) 819-824. Go to original source... Go to PubMed...
    14. G. Corrao, F. Nicotra, A. Parodi, et al., Cardiovascular protection by initial and subsequent combination of antihypertensive drugs in daily life practice, Hypertension 58 (2011) 566-572. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes